PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
To speed up drug applications, the FDA has laid out new guidance on how to request a platform designation that can smooth subsequent applications for biotechs working off the same reproducible ...
Microglia are specialized immune cells that make up around 10 % of all cells in the brain and spinal cord. They work by removing pathogenic bacteria, dead cells, aggregated proteins, and soluble ...
Cellugy has developed a platform technology that enables the creation of fully bio-based and biodegradable alternatives to carbon-intensive petrochemicals. Danish industrial biotech startup Cellugy ...
Ingram Micro is a global technology distributor that generates approximately $48 billion in annual revenue by serving as a critical link between technology vendors and resellers. As the President of ...
Forbes contributors publish independent expert analyses and insights. I'm an antitrust expert and former FTC general counsel. The Federal Trade Commission recently launched a public inquiry into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback